KLF-4 is a transcription factor with anti-proliferative effects in differentiated cells; in PC malignancies it acts as a tumor suppressor by upregulating p21CIP and downregulating c-Myc and cyclin D2 and is also associated with melphalan and carfilzomib drug resistance (57). Here, CCND2 is linked to pachyonychia congenita.